Yanfeng Liu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Skeletal Muscle

Tyrosine Kinase

Replacement Therapy

Top Venues

Nature communications

Clinical and translational medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Wenyun Guo, Songling Li, Yifei Qian, Linfeng Li, Fan Wang, Yu Tong, Qianyu Li, Zijun Zhu, Wei-Qiang Gao, Yanfeng Liu
KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression. Clinical and translational medicine 13 (10) (2023)
Yanfeng Liu, Yingying Xu, Fan Wang, Yu Tong, Hongchang Li, Xiaochun Wan, Xiaolu Yang, Liang Chen
Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress. Clinical and translational medicine 11 (12) (2022)
Yanan Wang, Mengjun Luo, Fan Wang, Yu Tong, Linfeng Li, Yu Shu, Ke Qiao, Lei Zhang, Guoquan Yan, Jing Liu, Hongbin Ji, You-Hua Xie, Yonglong Zhang, Wei-Qiang Gao, Yanfeng Liu
AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis. Nature communications 13 (1) (2022)
Yonglong Zhang, Hui Wang, Tao Chen, Haolu Wang, Xiaowen Liang, Yuchen Zhang, Jinlin Duan, Shenjiao Qian, Ke Qiao, Lei Zhang, Yanfeng Liu, Jian Wang
C24-Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation. Hepatology (Baltimore, Md.) 73 (2) (2020)
Yanfeng Liu, Shishi Tao, Lijuan Liao, Yang Li, Hongchang Li, Zhihuan Li, Lilong Lin, Xiaochun Wan, Xiaolu Yang, Liang Chen
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nature communications 11 (1) (2020)